GILEAD SCIENCES, INC.GILD

Market cap
$157.1B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents---------11,6315,9975,3385,4126,0859,991
Marketable Securities, Current1,19116117191011,7563,66617,92212,14912,7211,4111,1829731,179-
Accounts receivable, net1,6221,9511,7512,1004,6355,8544,5143,8513,3273,5824,8924,4934,7774,6604,420
Inventories1,2041,3901,7452,0561,3861,9551,5878018149221,6831,6181,5071,7871,710
Prepaid and other current assets--187--1,5191,5921,6611,6061,4402,0132,1411,7742,3743,052
Total current assets5,70813,9196,1567,27417,71424,76320,44531,82335,83630,29615,99614,77214,44316,08519,173
Property, plant and equipment, net7017741,1001,1661,6742,2762,8653,2954,0064,5024,9675,1215,4755,3175,414
Marketable Securities, Noncurrent3,219647204391,59811,60120,48511,1841,4231,4885021,3091,2451,163-
Intangible assets, net--11,73611,90011,07310,2478,97117,10015,73813,78633,12633,45528,89426,45419,948
Goodwill--1,0611,1691,1721,1721,1724,1594,1174,1178,1088,3328,3148,3148,314
Other long-term assets1811611591957311,0562,2142,7222,5557,4385,7084,9634,8004,7926,146
Total assets11,59317,30321,24022,49734,66451,83956,97770,28363,67561,62768,40767,95263,17162,12558,995
Accounts payable8031,2061,3271,2569551,1781,206814790713844705905550833
Accrued rebates------------3,4793,8023,892
Debt, Current64621,1692,697483983-2,7472,7482,4992,7571,5162,2731,7981,815
Other current liabilities------------4,5805,1305,464
Total current liabilities2,4652,5154,2706,3255,7619,8919,21911,63510,6059,75911,39711,61011,23711,28012,004
Long-term debt, net---3,93911,92121,19526,34630,79524,57422,09428,64525,17922,95723,18924,896
Long-term income taxes payable--1161625621,2431,7536,7945,9226,1155,0164,7673,9162,039830
Deferred tax liability-----------4,3562,6731,588724
Other long-term obligations271482281575353952965581,0401,0095,1289761,1791,2801,295
Preferred Stock, Value, Issued---------------
Common Stock, Value, Issued111221111111111
Additional paid-in capital4,6484,9035,6505,3872,3914444541,2642,2823,0513,8804,6615,5506,5007,700
Accumulated other comprehensive income3158-46-124301882781658085-6083228132
Retained earnings1,1841,7773,7056,10512,73218,00118,15419,01219,02419,38814,38116,32415,68716,30411,497
Total Gilead stockholders’ equity6,1226,8679,55111,74515,81919,11319,36320,50121,53422,65018,22121,06921,24022,83319,330
Noncontrolling interest2581282413753935794765914712519-5-31-84-84
Total stockholders’ equity6,1226,8679,55111,74515,81919,11319,36320,50121,53422,65018,22121,06421,20922,74919,246
Total liabilities and stockholders’ equity11,59317,30321,24022,49734,66451,83956,97770,28363,67561,62768,40767,95263,17162,12558,995